Category: Health & Medicines > Medicines > Beta Glucan
Country/Region: China State/Province: Tianjin
Main Products: Heparin
Business Type: Manufacturer, Trader
Year Established: 2004
Employees: 51 - 100 People
Plant Area: 3,000-5,000 square meters
Main Markets: South America 8% Africa 10% Eastern Asia 11% Domestic Market 12% North America 10% Eastern Europe 9% Southern Europe 9% Mid East 9% Northern Europe 9% Oceania 13%
Trade Capacity: FOB, EXW, DDP
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Tianjin
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: US$1 Million - US$2.5 Million
Export Revenue: US$1 Million - US$2.5 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: US$1 Million - US$2.5 Million
Export Percentage: 71% - 80%
Payment Modes: USD, EUR, CNY
Lead Time: 18 days
Import/Export Mode: LLC (Limited Liability Corp)